Cancer Drug Copiktra Linked To Increased Risk of Death, FDA Warns
The FDA warns the cancer drug, Copiktra, may be linked to an increased risk of death among patients.
Tag Archives: Clinical Trial
-
-
FDA Hearing To Determine if Makena Is Allowed Back On The Market
The FDA will hold a hearing later this year to determine whether Makena should be removed from the market because the pregnancy drug's risks appear to outweigh its benefits.
-
Public Citizen Calls For Investigation Into Ethics of Federal Epilepsy Study on Prolonged Seizures
Public Citizen is calling for investigations into an epilepsy seizure trial which it says put patients at risk due to a lack of including proper standards of care.
-
Prozac Side Effects Increase Fall Risks, Fail To Usher In Improvements After A Stroke: Study
A new study finds Prozac after a stroke increases the risk of bone fractures, falls and seizures, and does not appear to provide neurological benefits.
-
WHO Halts Hydroxychloroquine Study Amid Health Concerns
The WHO has temporarily halted a clinical trial looking into whether hydroxychloroquine could be used as a COVID-19 treatment after preliminary data suggested its use carried an increased risk of…
-
Fecal Transplant Led To Drug-Resistant E. Coli Infection, Doctors Say
A new case study highlights the risk of transferring drug-resistant infections between fecal transplant donors and recipients.
-
Expert Panel Recommends FDA Remove Makena From Market, Since Pricey Pregnancy Drug is Ineffective
An FDA Advisory board says the pregnancy drug Makena should be pulled from the market after clinical trials indicated it failed to be effective at preventing premature births.
-
Makena Recall Urged By Public Citizen Due To Lack of Effectiveness Preventing Preterm Births
Public Citizen is calling on the FDA to require a Makena recall after the drug failed to show it was effective in preventing preterm births in a recent clinical trial.
-
Breast Implant ALCL Lawsuit Claims Woman Was Enrolled In Study Without Warning Of Cancer Risks
A California woman says she was enrolled in a breast implant study without being told the full risks of cancer, leading to her eventually receiving Allergan breast implants and a…
-
Venclexta Side Effects May Increase Risk Of Death In Multiple Myeloma Patients: FDA
The FDA warns that clinical trials indicate Venclexta can increase the risk of death when given off-label to patients for the treatment of multiple myeloma.
